Literature DB >> 8405510

Salpingitis isthmica nodosa: a review of the literature, discussion of clinical significance, and consideration of patient management.

C S Jenkins1, S R Williams, G E Schmidt.   

Abstract

OBJECTIVES: To examine and discuss the pathology, diagnosis, incidence, and patient profile of salpingitis isthmica nodosa and to question its natural history, propose management strategies, and identify areas of promising research.
DESIGN: Over 50 studies were reviewed, evaluated, and compared to offer the clinician a foundation on which to generate treatment plans.
RESULTS: Salpingitis isthmica nodosa is diagnosed by the pathological presence of isthmic diverticula and may be suggested by characteristic changes on hysterosalpingogram. Its incidence in healthy, fertile women ranges from 0.6% to 11%, but it is significantly more common in the setting of ectopic pregnancy and infertility. There are no studies, retrospective or prospective, that clearly dictate appropriate therapy.
CONCLUSION: Given its progressive nature and probable deleterious effects on fertility, we propose that microtubal surgery be the definitive treatment for qualified women who have salpingitis isthmica nodosa.

Entities:  

Mesh:

Year:  1993        PMID: 8405510     DOI: 10.1016/s0015-0282(16)56207-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

Review 1.  Tubal transport of gametes and embryos: a review of physiology and pathophysiology.

Authors:  Mohammad Ezzati; Ovrang Djahanbakhch; Sara Arian; Bruce R Carr
Journal:  J Assist Reprod Genet       Date:  2014-08-13       Impact factor: 3.412

2.  Salpingitis isthmica nodosa: a case report.

Authors:  Parasappa Joteppa Yaranal; Vijayakumar Hegde
Journal:  J Clin Diagn Res       Date:  2013-11-10

3.  Microlaparoscopy and a GnRH agonist: a combined minimally invasive approach for the diagnosis and treatment of occlusive salpingitis isthmica nodosa associated with endometriosis.

Authors:  Oscar D Almeida
Journal:  JSLS       Date:  2005 Oct-Dec       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.